Logan K. Wink, MD

Assistant Professor, UC Department of Pediatrics

Phone 513-636-4611

Email logan.wink@cchmc.org

Autism spectrum disorders; Angelman syndrome.

Visit the Erickson/Wink lab website.

Dr. Logan Wink is an assistant professor of Clinical Psychiatry at Cincinnati Children’s Hospital Medical Center. Dr. Wink is a child and adolescent psychiatrist involved in clinical research and clinical care of individuals with developmental disabilities, including Autism Spectrum Disorders and Angelman Syndrome. 

Her primary research focus is improving clinical care of individuals with developmental disabilities through better understanding the pathology of these disorders and improving pharmacologic treatment.

MD: Indiana University School of Medicine, Indianapolis, IN.

Residency: Psychiatry, Indiana University School of Medicine, Indianapolis, IN.

Fellowship: Child Psychiatry, Indiana University School of Medicine, Indianapolis, IN.

Fellowship: Autism and Developmental Disabilities, Indiana University School of Medicine, Indianapolis, IN.

View PubMed Publications.

Erickson CA, Wink LK, Schaefer TL, Shaffer RC. Medication Management of Fragile X Syndrome. In The Comprehensive Guide to Autism, Patel VP, Preedy VR, Martin CR (eds), Springer Reference, Heidelberg, Germany. 2013. 

Wink LK, Erickson CA, McDougle CJ, Stigler KA. Pharmacotherapy of autism spectrum disorders. In The Handbook of Autism: A Concise Guide, Treadwell-Deering D, Kober D (eds), World Scientific, Inc., New Jersey, 2013.

Erickson CA, Early M, Stigler KA, Wink LK, Mullett JE, McDougle CJ. An Open-Label Naturalistic Pilot Study of Acamprosate in Youth with Autistic Disorder. J Child Adolesc Psychopharmacol. 2011 Dec 2.

Wink LK, Erickson CA, Stigler, KA, McDougle CJ. Riluzole in autistic disorder. J Child Adolesc Psychopharmacology. 2011;21(4):375-379. 

Kowalski JL, Wink LK, Blankenship K, Habenicht CD, Erickson CA, Stigler KA, McDougle CJ. Paliperidone Palmitate in a Child with Autistic Disorder. J Child Adolesc Psychopharmacology. 2011 Oct;21(5):491-3. 

Orsagh-Yentis DK, Wink LK, Erickson CA, Stigler KA, McDougle CJ. Buspirone for Bruxism in a Child with Pervasive Developmental Disorder-Not Otherwise Specified. J Child Adolesc Psychopharmacol. 2011 Dec. 

Erickson CA, Early M, Stigler KA, Wink LK, Mullett JE, McDougle CJ. An Open-Label Naturalistic Pilot Study of Acamprosate in Youth with Autistic Disorder. J Child Adolesc Psychopharmacol. 2011 Dec. 

Wink LK, Plawecki MH, Erickson CA, Stigler KA, McDougle CJ. Emerging drugs for the treatment of symptoms associated with autism spectrum disorders. Expert Opin Emerg Drugs. 2010 May.

Wink LK, Erickson CA, McDougle CJ. Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. Current Treat Options Neurology. 2010;12: 529-538.

Wink LK, Erickson CA, Chambers JE, McDougle CJ: Comorbid intellectual disability and borderline personality disorder: A case series. Psychiatry. 2010;73(3):279-289.

Acamprosate in Autistic Disorder. Co-Investigator. Autism Speaks. Jan 2013 - Dec 2015.

Acamprosate in Fragile X Syndrome. Co-Investigator. John Merck Fund Translational Research Program Award. Jan 2013 - Dec 2016.

FRAGILE X CLINICAL AND RESEARCH CONSORTIUM FORWARD REGISTRY AND DATABASE. Co-Investigator. National Fragile X Foundation/Centers for Disease Control. Sep 2012 - Dec 2014.